HSHHSH Health Technology Supplier Hub
Home › Suppliers › Kooth › Risk

Kooth: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

FY2025 revenue £63.3m (-5.1%).

Adjusted EBITDA £11.3m (from £15.8m); £21.6m cash, no debt.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

Apr 2026: Kooth reported 2025 revenue of £63.3m (2024: £66.7m) and adjusted EBITDA of £11.3m (2024: £15.8m), citing currency movements, lower California product development revenue and a delayed Michigan contract. It reported no debt and £21.6m cash.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

No data breaches, cyber incidents or regulator action involving Kooth found in HSH's search of the last 24 months. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

No product recalls, safety notices or clinical safety actions involving Kooth found in HSH's search of the last 24 months.

Researched 10 Nov 2026

Contract performance

Contract delivery, go-lives, terminations and disputes.

Apr 2026: Kooth said signing of its Michigan state contract was delayed, with revenue now expected in 2026. Its Soluna service in California had over 144,000 young people registered by end-2025.

Researched 10 Nov 2026